Evaluation of Healthcare Resource Utilization and Costs Among Patients with Chronic Myeloid Leukemia after Disease Progression

被引：0
|
作者：
Jabbour, Elias [1 ]
Lin, Jay [2 ]
Siegartel, Lisa R. [3 ]
Lingohr-Smith, Melissa [2 ]
Menges, Brandy [2 ]
Makenbaeva, Dinara [3 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Novosys Hlth, Green Brook, NJ USA
[3] Bristol Myers Squibb, Plainsboro, NJ 08536 USA
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.3573.3573
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3573
引用
收藏
页数：5
相关论文
共 50 条
  • [21] HIGHER RESOURCE UTILIZATION AND HEALTHCARE COSTS IN TREATED CHRONIC HEPATITIS B PATIENTS WITH CHRONIC KIDNEY DISEASE
    Nguyen, Mindie H.
    Lim, Joseph K.
    Liou, Iris
    Fraysse, Jeremy
    Meyer, Nicole
    Dusheiko, Geoffrey
    Gordon, Stuart C.
    GASTROENTEROLOGY, 2017, 152 (05) : S1087 - S1087
  • [22] Time to Next Treatment, Healthcare Resource Utilization, and Healthcare Costs Among Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Following FirstLine Ibrutinib
    Challagulla, Swetha
    Emond, Bruno
    Volodarsky, Raisa R.
    Young, Alex
    Manceur, Ameur
    Karve, Sudeep
    BLOOD, 2021, 138
  • [23] Healthcare resource utilization and costs of major atherothrombotic vascular events among patients with peripheral artery disease after revascularization
    Desai, Urvi
    Kharat, Akshay
    Hess, Connie N.
    Milentijevic, Dejan
    Laliberte, Francois
    Zuckerman, Peter
    Benson, John
    Lefebvre, Patrick
    Hiatt, William R.
    Bonaca, Marc P.
    JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 402 - 409
  • [24] Healthcare resource utilization and costs among psoriasis patients treated with biologics, overall and by disease severity
    Murage, Mwangi J.
    Anderson, Amanda
    Oliveria, Susan A.
    Casso, Deborah
    Ojeh, Clement K.
    Muram, Talia M.
    Merola, Joseph F.
    Araujo, Andre B.
    JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (08) : 745 - 754
  • [25] Real world treatment patterns, adverse events and healthcare resource utilization and costs among chronic lymphocytic leukemia (CLL) patients in the US
    Kabadi, Shaum
    Olufade, Temitope O.
    Le, Lisa
    Byfield, Stacey Dacosta
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 78 - 79
  • [26] HEALTHCARE UTILIZATION AND COSTS ASSOCIATED WITH MULTIPLE SWITCHING OF TYROSINE KINASE INHIBITOR THERAPY IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA
    Kropf, P.
    Barnes, G.
    Tang, B.
    Pathak, A.
    Issa, J.
    VALUE IN HEALTH, 2015, 18 (03) : A199 - A199
  • [27] Healthcare Resource Utilization and Costs in US Patients with Newly Diagnosed Acute Myeloid Leukemia Treated with Intensive Induction Chemotherapy
    Huggar, David
    Knoth, Russell L.
    Copher, Ronda
    Cao, Zhun
    Lipkin, Craig
    McBride, Ali
    LeBlanc, Thomas W.
    BLOOD, 2021, 138
  • [28] Healthcare resource utilization and costs associated with inflammatory bowel disease among patients with chronic inflammatory diseases: a retrospective cohort study
    Hudesman, David P.
    Chakravarty, Soumya D.
    Emond, Bruno
    Ellis, Lorie A.
    Lefebvre, Patrick
    Sadik, Kay
    Scher, Jose U.
    BMC RHEUMATOLOGY, 2020, 4 (01)
  • [29] Healthcare resource utilization and costs associated with inflammatory bowel disease among patients with chronic inflammatory diseases: a retrospective cohort study
    David P. Hudesman
    Soumya D. Chakravarty
    Bruno Emond
    Lorie A. Ellis
    Patrick Lefebvre
    Kay Sadik
    Jose U. Scher
    BMC Rheumatology, 4
  • [30] HEALTHCARE RESOURCE UTILIZATION AND DIRECT MEDICAL COSTS AMONG ADULT PATIENTS WITH CHRONIC HEPATITIS C IN CHINA
    Wei, L.
    Yu, N.
    Gao, S.
    Wang, Q.
    VALUE IN HEALTH, 2018, 21 : S87 - S87
12345